KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Exchange Rate Effect (2016 - 2025)

Novavax (NVAX) has 13 years of Exchange Rate Effect data on record, last reported at -$1.7 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 84.05% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached $5.9 million, up 175.96%, while the annual FY2025 figure was $5.9 million, 175.96% up from the prior year.
  • Exchange Rate Effect reached -$1.7 million in Q4 2025 per NVAX's latest filing, down from $658000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $9.3 million in Q3 2023 and bottomed at -$10.7 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $31250.0, with a median of $251000.0 recorded in 2024.
  • Peak YoY movement for Exchange Rate Effect: crashed 2311.52% in 2021, then surged 5167.95% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $916000.0 in 2021, then surged by 365.39% to $4.3 million in 2022, then plummeted by 31.57% to $2.9 million in 2023, then plummeted by 467.4% to -$10.7 million in 2024, then skyrocketed by 84.05% to -$1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$1.7 million in Q4 2025, $658000.0 in Q3 2025, and $7.9 million in Q2 2025.